Publication Name	World Journal of Gastroenterology
Manuscript ID	19223
Country	Switzerland

Received	2015-04-30 17:58
Peer-Review Started	2015-05-08 09:38
To Make the First Decision	2015-08-26 10:04
Return for Revision	2015-08-27 13:50
Revised	2015-09-10 01:52
Second Decision	2015-11-09 16:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-11-24 17:13
Articles in Press	2015-11-24 17:13
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-12-21 12:07
Typeset the Manuscript	2016-02-23 09:42
Publish the Manuscript Online	2016-02-25 19:03

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Advanced gastric cancer: Current treatment landscape and future perspectives
Manuscript Source	Invited Manuscript
All Author List	Antonia Digklia and Anna Dorothea Wagner
Funding Agency and Grant Number
Corresponding Author	Anna Dorothea Wagner, MD, Departement d’Oncologie, Centre Hospitalier Universitaire Vaudois, Bugnon 46, 1011 Lausanne, Switzerland. dorothea.wagner@.chuv.ch
Key Words	Gastric cancer; phase Ⅲ; clinical trials; chemotherapy; targeted therapy; perspectives
Core Tip	With the integration of both ramucirumab and transtuzumab, treatment options for advanced gastric cancer have increased significantly in recent years. Therefore, a reconsideration of treatment options and results for gastric cancer is necessary. This paper discusses results of phase Ⅲ trials for both standard chemotherapy and targeted treatments in metastatic gastric cancer. Furthermore, results of selected early-phase clinical trials, for example on immune checkpoint inhibitors, are discussed.
Publish Date	2016-02-25 19:03
Citation	Digklia A, Wagner AD. Advanced gastric cancer: Current treatment landscape and future perspectives. World J Gastroenterol 2016; 22(8): 2403-2414
URL	http://www.wjgnet.com/1007-9327/full/v22/i8/2403.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i8.2403

Full Article (PDF)	WJG-22-2403.pdf
Full Article (Word)	WJG-22-2403.doc
Manuscript File	19223-Review.docx
Answering Reviewers	19223-Answering reviewers.pdf
Audio Core Tip	19223-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19223-Conflict-of-interest statement.pdf
Copyright License Agreement	19223-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	19223-Language certificate.pdf
Peer-review Report	19223-Peer-review(s).pdf
Scientific Misconduct Check	19223-Scientific misconduct check.pdf
Scientific Editor Work List	19223-Scientific editor work list.pdf